Apotex

85 articles about Apotex

• Apotex Launches First Generic Version Of Merck & Co.'s Nasonex

  3/22/2016

• Shakeup at Canada's Largest Pharma Firm Apotex

  3/17/2015

• Apotex Inc. Announces FDA Has Accepted For Filing its Biosimilar Application for Filgrastim (Grastofil)

  2/18/2015

• Apotex Inc. Announces FDA Has Accepted For Filing Its Biosimilar Application For Pegfilgrastim

  12/17/2014

• Apotex Inc. Sues Health Canada Over An ‘Unlawful’ Ban On Its Drugs

  11/24/2014

• Apotex Inc. Release: Setting The Record Straight: Products Are Safe And Effective

  9/26/2014

• Information Update - Health Canada Requests Quarantine Of Products For Canadian Market From Apotex Inc. Facility In Bangalore, India

  9/25/2014

• Apotex Inc. Release: Medicine To Treat 1 In 10 Haitians Arrives In Port-au-Prince

  9/11/2014

• Appointment Announcement - Dr. Jeremy B. Desai, President and CEO, Apotex Inc.

  8/27/2014

• Apotex Inc. Release: NAFTA Tribunal Decision Supports FDA And Its Actions

  8/26/2014

• Apotex Inc. Recalls One Lot Of Organ Rejection Drug Apo-Mycophenolic Acid Due To Label Error

  8/18/2014

• Apotex Inc. Ordered To Pony Up $76 Million To AstraZeneca PLC In Damages

  12/4/2013

• Apotex Inc. is in the FDA Dog House, Again

  3/21/2013

• Nuvo Research Inc. Announces Settlement Agreement With Apotex Inc. in PENNSAID&#0174 Generic Litigation

  1/29/2013

• Supreme Court Denies Apotex Inc.'s Petition for a Writ of Certiorari

  3/22/2012

• Apotex Inc. Drug Maker Sues U.S. for $520 Million Under NAFTA

  3/15/2012

• Sanofi (France), Bristol-Myers Squibb Company Receive Nearly $445 Million From Apotex Inc. Over Generic Plavix

  2/9/2012

• GlaxoSmithKline Partner Pronova BioPharma Settles Drug Case with Apotex Inc.; Apotex to Sell Generic Lovaza in U.S. from Q1 2015

  3/30/2011

• Pfizer Inc. Sues Apotex Inc., Mylan Inc. to Block Generic Viagra

  11/1/2010

• Apotex Inc. to Distribute Important Transdermal System for Management of Chronic Pain in the U.S. Market

  10/20/2009